Ever wonder how artificial intelligence or 3D printing is used to solve medical problems,

or how research is discovering new ways to slow or even stop medical conditions we used to think

of as untreatable.

I'm Kathy Worser.

Listen to Tomorrow's Cure, a podcast where I interview experts from Mayo Clinic and

other renowned organizations. What they describe may sound futuristic, but listen and you'll find out tomorrow's cure is already here.

Find it now wherever you get your podcasts.

We'll know shortly what government negotiators came up with on Medicare drug prices.

I'm David Brancatia. We're awaiting the results as early as today the first government negotiation with pharmaceutical companies on

Medicare drug prices the system was designed to lower the cost of 10

commonly used medicines this is for people on Medicare and could save

taxpayers an estimated six billion dollars.

Marketplaces Henry up has more.

Private insurers routinely negotiate with pharmaceutical companies over the cost of

prescription drugs, but for years Medicare wasn't able to do so.

That changed under the Inflation Reduction Act, which President Biden signed into law

two years ago tomorrow. Its first round of negotiations are for drugs that treat blood clots, diabetes, arthritis, cancer,

and other common conditions.

Medicare spent $46 billion on the medications in 2022, according to the Department of Health and Human Services.

The new prices will take effect in 2026, and the program is set to expand in the years ahead.

Medicare will be able to negotiate prices for 15 more

drugs next year and an additional 20 in later years. The pharmaceutical industry has

...